Jacobson Mark L.
Insider CIK 1805812 · AXSM Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-09-03 | 2026-09-03 | 10,000 | — | $0 | 104,954 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-09-03 | 2026-09-03 | 10,000 | $12.95 | $129.5K | 10,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 10,000 | $208.65 | $2.09M | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-09-03 | 2026-09-03 | 10,000 | — | $0 | 104,954 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 10,000 | $208.65 | $2.09M | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-09-03 | 2026-09-03 | 10,000 | $12.95 | $129.5K | 10,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-05-05 | 2026-05-05 | 233 | — | $0 | 114,954 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-05-05 | 2026-05-05 | 233 | $12.95 | $3.0K | 233 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-05-05 | 2026-05-05 | 233 | $228.18 | $53.2K | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-05 | 4,517 | — | $0 | 115,187 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-05-04 | 2026-05-05 | 4,517 | $227.94 | $1.03M | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-05 | 4,517 | $12.95 | $58.5K | 4,517 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-04-21 | 2026-04-23 | 8,669 | — | $0 | 8,669 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-02-26 | 2026-02-27 | 35,378 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-02-26 | 2026-02-27 | 19,663 | — | $0 | 19,663 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-02-26 | 2026-02-27 | 35,378 | $161.88 | $5.73M | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-02-26 | 2026-02-27 | 35,378 | $2.85 | $100.8K | 35,378 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-09-22 | 2025-09-22 | 10,000 | — | $0 | 35,378 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-09-22 | 2025-09-22 | 10,000 | $2.85 | $28.5K | 10,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-22 | 2025-09-22 | 10,000 | $115.96 | $1.16M | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-09-16 | 2025-09-17 | 15,000 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-09-16 | 2025-09-17 | 25,000 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-16 | 2025-09-17 | 40,000 | $114.23 | $4.57M | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-09-16 | 2025-09-17 | 15,000 | $4.85 | $72.8K | 40,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-09-16 | 2025-09-17 | 25,000 | $4.95 | $123.8K | 25,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-16 | 2025-09-17 | 5,783 | $116.19 | $671.9K | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-06-09 | 2025-06-10 | 25,000 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-06-09 | 2025-06-10 | 25,000 | $110.44 | $2.76M | 5,783 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-06-09 | 2025-06-10 | 25,000 | $8.02 | $200.5K | 30,783 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-05-28 | 2025-05-28 | 20,000 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-05-28 | 2025-05-28 | 20,000 | $6.47 | $129.4K | 25,783 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-05-28 | 2025-05-28 | 20,000 | $103.45 | $2.07M | 5,783 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-05-27 | 2025-05-28 | 20,673 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-05-27 | 2025-05-28 | 20,673 | $6.47 | $133.8K | 26,456 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-05-27 | 2025-05-28 | 20,673 | $104.66 | $2.16M | 5,783 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-24 | 2025-02-25 | 10,769 | — | $0 | 10,769 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 10,875 | — | $0 | 10,875 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 10,769 | — | $0 | 10,769 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-08-09 | 2024-08-09 | 47,739 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-08-09 | 2024-08-09 | 47,739 | $84.26 | $4.02M | 5,783 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-08-09 | 2024-08-09 | 47,739 | $4.04 | $192.9K | 53,522 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-05-29 | 2024-05-29 | 13,693 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-05-29 | 2024-05-29 | 7,910 | $74.31 | $587.8K | 5,783 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-05-29 | 2024-05-29 | 13,693 | $1.30 | $17.8K | 13,693 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-01 | 24,662 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-04-01 | 2024-04-01 | 24,662 | $77.24 | $1.90M | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-04-01 | 2024-04-01 | 24,662 | $1.30 | $32.1K | 24,662 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 32,825 | — | $0 | 32,825 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 18,027 | — | $0 | 18,027 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 41,424 | — | $0 | 41,424 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 23,491 | — | $0 | 23,491 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 89,405 | — | $0 | 89,405 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 47,990 | — | $0 | 47,990 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-11-12 | 2021-11-15 | 41,638 | — | $0 | 41,638 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 41,638 | — | $0 | 41,638 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 22,163 | — | $0 | 22,163 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-12-23 | 48,237 | — | $0 | 48,237 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-12-23 | 14,767 | — | $0 | 14,767 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 18,645 | — | $0 | 18,645 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 60,880 | — | $0 | 60,880 | SEC↗ |